Navigation Links
Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
Date:2/6/2008

Ranbaxy to Offer Both Suspension and Tablets

PRINCETON, N.J., Feb. 6 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Cefuroxime Axetil for Oral Suspension USP, 125 mg/5mL and 250 mg/5mL. The Office of Generic Drugs, U.S. Food and Drug Administration, has determined the Ranbaxy formulations to be bioequivalent and have the same therapeutic effect as that of the reference listed drug Ceftin(R) by GlaxoSmithKline. Total annual market sales for Cefuroxime Axetil Suspension were $28.7 million (IMS - MAT: December 2007).

Cefuroxime Axetil Suspension is indicated for the treatment of pediatric patients 3 months to 12 years of age with mild to moderate infections caused by susceptible strains of the designated microorganisms in the following conditions: Pharyngitis/Tonsillitis, Acute Bacterial Otitis Media and Impetigo.

"Ranbaxy is pleased to receive this approval for Cefuroxime Axetil Suspension that now allows us to offer both dosage forms for a product that is highly prescribed. We will offer Cefuroxime Axetil Suspension as a pleasant tasting liquid intended primarily for children that will ease in the acceptance and administration of this anti-infective. This product will further expand our product portfolio of affordable generic alternatives and will be launched immediately to all classes of trade," said Jim Meehan, Vice President of Sales and Distribution for RPI.

Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India's largest pharmaceutical company. RPI is engaged in the sale and distribution of generic and branded prescription products in the U.S. healthcare system.

Ranbaxy Laboratories Limited, headquartered in India, is an integrated, research
'/>"/>

SOURCE Ranbaxy Laboratories Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Tablets (OTC), 5mg and 10mg
2. Ranbaxy Receives Tentative Approval For Valsartan Tablets
3. Ranbaxy First to Gain Approval to Manufacture and Market Clarithromycin for Oral Suspension, USP
4. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
5. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
6. Shareholder Class Action Filed Against American Dental Partners, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
7. Medicare Cuts in Bush Budget Shortsighted, Far Off the Mark in Protecting Seniors Long Term Care Needs, Sustaining Nursing Home Quality Gains
8. Hispanic Radio Listeners Nationwide to Support Life-Saving Efforts Against Childhood Cancer
9. Movement Against Cancer, a Cancer Patient Advocacy Group in Russia, Launches an Effort to Inform Russian Authorities and the Public About Inadequate Access of Innovative and Effective Cancer Treatments for Cancer Patients in Russia
10. National Health Care Alliance Gains New Members Against Aetnas New Anesthesia Policy
11. Obesity Action Coalition Calls on the State of Mississippi House of Representatives to Withdraw House Bill 282 Discriminating Against Those Affected by Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... August 28, 2015 , ... “ Frequentz ” was featured on ... and coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the ... how this software allows businesses to track product movement from beginning to end. , ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... of the Veterans Award, honoring military veterans leading in business. Mr. Troy ... , The inaugural Nashville Business Journal's 2015 Veterans Awards will recognize ...
(Date:8/28/2015)... ... 28, 2015 , ... The Quatela Center for Plastic Surgery is excited to ... nonsurgical product approved by the Food and Drug Administration to eliminate submental fat, also ... William Koenig are among the premier cosmetic surgeons in Rochester to offer this ...
(Date:8/28/2015)... ... August 28, 2015 , ... Healthpointe ... seeking to go deep sea diving. The act of recreational diving exposes ... for these reasons, it is vital that all recreational and professional divers undergo ...
(Date:8/28/2015)... ... 28, 2015 , ... United Benefit Advisors (UBA), the nation’s ... as its newest Partner Firm. Founded in 1924 and headquartered in Pittsburgh, Pennsylvania, ... their goals. Within the past 10 years, TJS Insurance Group has emerged as ...
Breaking Medicine News(10 mins):Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:Healthpointe Now Offering Scuba Physicals 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 3
... 2008 at 11:00 AM ET, LIVINGSTON, N.J., May ... recognized leader in advanced,injection technologies, today announced that the ... ended March 31, 2008 on Thursday,May 15, 2008., ... 2008, beginning,at 11:00 AM Eastern time, and invites all ...
... funding to PBTF Institute at Duke accelerates search for ... ... The Pediatric Brain,Tumor Foundation (PBTF) is giving an additional $6 million ... to $12 million., To view the Multimedia News Release, go ...
... for prehypertensive people in morning use, researchers report , , ... can control prehypertension, but only if it is taken ... taken every morning didn,t lower the blood pressure of ... C. Hermida reported Wednesday at the American Society of ...
... Del., May 14 AstraZeneca (NYSE:,AZN) today announced ... has,approved SEROQUEL(R) (quetiapine fumarate tablets) for the maintenance,treatment ... therapy to,lithium or divalproex. SEROQUEL is approved by ... also the only single agent approved by the ...
... AMRN ) today announced a private placement ... ("ADSs") with several new,institutional and accredited investors, and ... $60 million funded over two equal tranches., ... agreements for,gross proceeds of up to $56 million, ...
... Mass., and SYDNEY, Australia, May 14 /PRNewswire-FirstCall/,-- HeartWare Limited ... an investor presentation at the Seventh Annual JMP Securities ... Wednesday, May 21, 2008. The,conference is being held at ... webcast of the Company,s presentation at the conference will ...
Cached Medicine News:Health News:Milestone Scientific to Announce First Quarter 2008 Results on Thursday, May 15, 2008 2Health News:Video: Pediatric Brain Tumor Foundation Gives $6 Million Grant to Duke 2Health News:Aspirin at Bedtime Lowers Blood Pressure 2Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 2Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 3Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 4Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 5Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 6Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 7Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 8Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 9Health News:Amarin Announces Private Placement for up to $60 Million 2Health News:Amarin Announces Private Placement for up to $60 Million 3Health News:Amarin Announces Private Placement for up to $60 Million 4Health News:Amarin Announces Private Placement for up to $60 Million 5Health News:HeartWare to Present at Seventh Annual JMP Securities Research Conference 2
(Date:8/27/2015)... , Aug. 27, 2015  The Academy ... Food and Drug Administration,s (FDA,s) draft guidance and ... products and biosimilars, to bear a nonproprietary name ... has been seeking a decision from the FDA ... diverse health care stakeholders urging the agency to ...
(Date:8/27/2015)... 2015 ieCrowd™ today announced the achievement ... of the company,s supplemental oxygen delivery device, Smart ... developed by ieCrowd,s subsidiary Smart Oxygen Solutions TM ... for oxygen based on level of activity.  The ... the Smart Oxygen device would require a series ...
(Date:8/27/2015)...   Women Grow , the fastest-growing professional networking organization ... the Cannabis World Congress & Business Exposition (CWCBExpo) ... business-focused educational sessions. CWCBExpo in LA will take place September ... Convention Center in Los Angeles, CA , ... for the marijuana industry. The Women Grow tracks ...
Breaking Medicine Technology:AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 2Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 3Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 4
... 2010 Reportlinker.com announces that a new market research ... Europe Orthopedic Devices Market Outlook to 2016 ... Market Outlook to 2016 Summary ... Outlook to 2016" provides key market data on the ...
... NEW YORK, Dec. 8, 2010 Reportlinker.com announces ... in its catalogue: Asia-Pacific Dental ... http://www.reportlinker.com/p0336613/Asia-Pacific-Dental-Devices-Market-Outlook-to-2016.html Asia-Pacific Dental ... SummaryGlobalData,s new report, "Asia-Pacific Dental Devices Market Outlook ...
Cached Medicine Technology:Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 2Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 3Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 4Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 5Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 6Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 7Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 8Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 9Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 10Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 11Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 12Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 13Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 14Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 15Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 16Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 17Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 18Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 19Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016 20Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 2Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 3Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 4Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 5Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 6Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 7Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 8Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 9Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 10Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 11Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 12Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 13Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 14Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 15
The BioCheck LH ELISA is intended for the quantitative determination of luteinizing hormone (LH) in human serum. This assay is useful in the diagnosis and treatment of gonadal dysfunction....
... glycoprotein secreted by the anterior pituitary gland. ... intact LH molecule is a noncovalently-linked dimer ... have homologous alpha-subunits, however each hormone has ... production and secretion are stimulated by gonadotropin-releasing ...
The NPT7 blood gas analyzer measures pH/blood gases and oximetry on 90 L sample volume with a two-step sampling procedure. Clinical tests compare NPT7 accuracy to that of benchtop analyzers. 30 sampl...
... a fully automated, upgradeable platform that ... analyzer along with a customer care ... to focus on patient care. ... are essential to efficient blood gas ...
Medicine Products: